Genomic variability of hepatitis G virus/GBV-C at the NS3 region: clinical implications.
A new hepatitis virus, named GBV-C or hepatitis G virus (HGV), closely related to the hepatitis C virus (HCV), was identified in 1994. The existence of quasispecies in HCV is very important. In this work polymerase chain reaction amplification of the NS3 region of the genome of GBV-C/HGV and heteroduplex mobility assay (HMA) were combined to investigate the presence of quasispecies in patients with chronic infection by GBV-C/HGV. Patients with chronic infection by HCV were used to validate the method. The HMA was also used to investigate the similarity between the cited genomic region of GBV-C/HGV in different infected patients. A high degree of heterogeneity was found for HGV existing as quasispecies and as differences between samples. This is of extreme importance because of the intrinsic clinical and pathogenic implications of quasispecies of a virus capable of producing disease, and is in accord with other studies which report on the genomic variability of the NS3 region.
García
F
F
Department of Microbiology, Hospital Clínico Universitario San Cecilio, Granada, Spain.
García
F
F
Bernal
M C
MC
Piédrola
G
G
Maroto
M C
MC
D000998:Antiviral Agents / Q000627:therapeutic use; D018067:Flaviviridae / Q000235:genetics* / Q000302:isolation & purification; D014644:Genetic Variation; D016679:Genome, Viral; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000821:virology; D006525:Hepatitis, Viral, Human / Q000188:drug therapy / Q000821:virology*; D020180:Heteroduplex Analysis; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D016896:Treatment Outcome; D019562:Viral Load
D000998:Antiviral Agents; D016898:Interferon-alpha